565 related articles for article (PubMed ID: 22058059)
1. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
2. The CXCL12 G801A polymorphism and cancer risk: evidence from 17 case-control studies.
Gong H; Tan M; Wang Y; Shen B; Liu Z; Zhang F; Liu Y; Qiu J; Bao E; Fan Y
Gene; 2012 Nov; 509(2):228-31. PubMed ID: 22939870
[TBL] [Abstract][Full Text] [Related]
3. Association of the interleukin-10 gene polymorphism (-1082A/G) with systemic lupus erythematosus: a meta-analysis.
Zhou M; Ding L; Peng H; Wang B; Huang F; Xu WD; Li JH; Ye XR; Pan HF; Ye DQ
Lupus; 2013 Feb; 22(2):128-35. PubMed ID: 23192326
[TBL] [Abstract][Full Text] [Related]
4. The -1082A/G polymorphism in the Interleukin-10 gene and the risk of rheumatoid arthritis: a meta-analysis.
Zhang J; Zhang Y; Jin J; Li M; Xie K; Wen C; Cheng R; Chen C; Lu J
Cytokine; 2011 Nov; 56(2):351-5. PubMed ID: 21764596
[TBL] [Abstract][Full Text] [Related]
5. The Cox-2 -1195 G > A polymorphism and cancer risk: a meta-analysis of 25 case-control studies.
Tang Z; Nie ZL; Pan Y; Zhang L; Gao L; Zhang Q; Qu L; He B; Song G; Zhang Y; Shukui Wang
Mutagenesis; 2011 Nov; 26(6):729-34. PubMed ID: 21734230
[TBL] [Abstract][Full Text] [Related]
6. Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms in cancer: a meta-analysis.
Jing JJ; Li M; Yuan Y
Gene; 2012 May; 499(2):237-42. PubMed ID: 22441122
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-10-1082A/G polymorphism and inflammatory bowel disease susceptibility: a meta-analysis based on 17,585 subjects.
Zhu H; Lei X; Liu Q; Wang Y
Cytokine; 2013 Jan; 61(1):146-53. PubMed ID: 23046617
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor alpha -308G/A polymorphism and risk of the four most frequent cancers: a meta-analysis.
Wang J; Cao C; Luo H; Xiong S; Xu Y; Xiong W
Int J Immunogenet; 2011 Aug; 38(4):311-20. PubMed ID: 21624061
[TBL] [Abstract][Full Text] [Related]
9. Genetic association of interleukin-10 promoter polymorphisms and susceptibility to diffuse large B-cell lymphoma: a meta-analysis.
Cao HY; Zou P; Zhou H
Gene; 2013 May; 519(2):288-94. PubMed ID: 23485354
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-10 G-1082A and C-819T polymorphisms as possible molecular markers of urothelial bladder cancer.
Ahirwar D; Mandhani A; Mittal RD
Arch Med Res; 2009 Feb; 40(2):97-102. PubMed ID: 19237018
[TBL] [Abstract][Full Text] [Related]
11. The associations between two polymorphisms in the interleukin-10 gene promoter and breast cancer risk.
Yu KD; Chen AX; Yang C; Fan L; Huang AJ; Shao ZM
Breast Cancer Res Treat; 2012 Jan; 131(1):27-31. PubMed ID: 20737205
[TBL] [Abstract][Full Text] [Related]
12. No association between a progesterone receptor gene promoter polymorphism (+331G>A) and breast cancer risk in Caucasian women: evidence from a literature-based meta-analysis.
Yu KD; Chen AX; Shao ZM
Breast Cancer Res Treat; 2010 Aug; 122(3):853-8. PubMed ID: 20076999
[TBL] [Abstract][Full Text] [Related]
13. Association of Interleukin-10 -1082A>G (rs1800896) Polymorphism with Predisposition to Breast Cancer: a Meta-Analysis based on 17 Case-Control Studies.
Abedinzadeh M; Neamatzadeh H; Jafari M; Forat-Yazdi M; Nasiri R; Farahnak S; Foroughi E; Zare-Shehneh M
Rev Assoc Med Bras (1992); 2018 Aug; 64(8):756-764. PubMed ID: 30673047
[TBL] [Abstract][Full Text] [Related]
14. Association between CTLA-4 exon-1 +49A>G polymorphism and primary biliary cirrhosis risk: a meta-analysis.
Huang Q; Shao F; Wang C; Qiu LJ; Hu YG; Yu JH
Arch Med Res; 2011 Apr; 42(3):235-8. PubMed ID: 21722820
[TBL] [Abstract][Full Text] [Related]
15. Relationship between IL-10 gene -1082A/G and -592C/A polymorphisms and the risk of hepatitis C infection: a meta-analysis.
Sun XR; Wu J; Shi KQ; Tang KF
J Viral Hepat; 2013 Sep; 20(9):602-11. PubMed ID: 23910644
[TBL] [Abstract][Full Text] [Related]
16. Association between IL13 gene polymorphisms and susceptibility to cancer: a meta-analysis.
Su T; Mi Y; Zhang L; Wang S; Lu H; Shi L; Sun H; Wu X; Zhang W; Zuo L; Zou J
Gene; 2013 Feb; 515(1):56-61. PubMed ID: 23246181
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-10-1082A>G polymorphism and lymphoma risk: a meta-analysis.
Yu X; Chen B; Cheng J; Gao C; Zhang X; Bao W
Cancer Biomark; 2014; 14(5):381-8. PubMed ID: 25171480
[TBL] [Abstract][Full Text] [Related]
18. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
[TBL] [Abstract][Full Text] [Related]
19. IL-10 polymorphisms and prostate cancer risk: a meta-analysis.
Shao N; Xu B; Mi YY; Hua LX
Prostate Cancer Prostatic Dis; 2011 Jun; 14(2):129-35. PubMed ID: 21339768
[TBL] [Abstract][Full Text] [Related]
20. Interleukin 1 beta (IL1B) promoter polymorphism and cancer risk: evidence from 47 published studies.
He B; Zhang Y; Pan Y; Xu Y; Gu L; Chen L; Wang S
Mutagenesis; 2011 Sep; 26(5):637-42. PubMed ID: 21653279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
